The impact of equol-producing status in modifying the effect of soya isoflavones on risk factors for CHD: a systematic review of randomised controlled trials

Recent studies suggest that the ability to produce equol, a metabolite of the soya isoflavone daidzein, is beneficial to coronary health. Equol, generated by bacterial action on isoflavones in the human gut, is biologically more potent than dietary sources of isoflavones. Not all humans are equol pr...

Full description

Bibliographic Details
Main Authors: Rahel L. Birru, Vasudha Ahuja, Abhishek Vishnu, Rhobert W. Evans, Yoshihiro Miyamoto, Katsuyuki Miura, Takeshi Usui, Akira Sekikawa
Format: Article
Language:English
Published: Cambridge University Press 2016-01-01
Series:Journal of Nutritional Science
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2048679016000185/type/journal_article